These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2268866)

  • 41. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
    Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
    Iakovlev SV; Suvorova MP; DvoretskiÄ­ LI; Vlasenko NA; Shakhova TV
    Antibiot Khimioter; 1998; 43(6):7-11. PubMed ID: 9644527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
    Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis.
    Wilson R; Langan C; Ball P; Bateman K; Pypstra R;
    Respir Med; 2003 Mar; 97(3):242-9. PubMed ID: 12645831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overview of experience with ofloxacin in respiratory tract infection.
    Ball P
    Scand J Infect Dis Suppl; 1990; 68():56-63. PubMed ID: 2218424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of cefuroxime axetil and amoxycillin in the treatment of lower respiratory tract infections.
    Spencer RC
    J Chemother; 1989 Jul; 1(4 Suppl):765-6. PubMed ID: 16312629
    [No Abstract]   [Full Text] [Related]  

  • 47. Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis.
    Davies BI; Maesen FP; Baur C
    Eur J Clin Microbiol; 1986 Apr; 5(2):226-31. PubMed ID: 2941287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis.
    Langan C; Clecner B; Cazzola CM; Brambilla C; Holmes CY; Staley H
    Int J Clin Pract; 1998; 52(5):289-97. PubMed ID: 9796558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aztreonam in patients with acute purulent exacerbations of chronic bronchitis: failure to prevent emergence of pneumococcal infections.
    Davies BI; Maesen FP; Teengs JP
    J Antimicrob Chemother; 1985 Mar; 15(3):375-84. PubMed ID: 3922936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis.
    Van Herwaarden CL; Langan CE; Siemon G; Rudolph C; Keyserling CH; Nemeth MA; Tack KJ
    Int J Infect Dis; 2000; 4(1):26-33. PubMed ID: 10689211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.
    James NC; Donn KH; Collins JJ; Davis IM; Lloyd TL; Hart RW; Powell JR
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1860-3. PubMed ID: 1952858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A dose-ranging study of cefuroxime axetil in the treatment of lower respiratory tract infections in general practice.
    Spencer RC; Griggs JV; Brown GW
    Drugs Exp Clin Res; 1987; 13(2):101-3. PubMed ID: 3582133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Amoxicillin/clavulanic acid (875/125 mg). New pharmacodynamic aspects].
    Lode H
    Dtsch Med Wochenschr; 1999 Dec; 124(48):1459-61. PubMed ID: 10615328
    [No Abstract]   [Full Text] [Related]  

  • 55. [Efficacy and tolerability of cefuroxime-axetil in infections of the upper respiratory tract. Comparative study with cefadroxil].
    Dupuis G; Ebbo D; Evennou A; Pappo M
    Rev Laryngol Otol Rhinol (Bord); 1989; 110(1):123-6. PubMed ID: 2491707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Respiratory tract infections--clinical results with ofloxacin].
    Shah PM; Knothe H
    Infection; 1986; 14 Suppl 1():S79-81. PubMed ID: 3514472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical trial of bacampicillin in acute bacterial infections.
    Ogunyemi O
    Clin Ther; 1983; 5(5):472-4. PubMed ID: 6352033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Various prospective approaches to the treatment of nonspecific lung diseases].
    Sil'vestrov VP; Vanina NF
    Ter Arkh; 1980; 52(3):3-12. PubMed ID: 6966837
    [No Abstract]   [Full Text] [Related]  

  • 60. Cefuroxime axetil in the treatment of bronchitis: comparison with amoxycillin in a multicentre study in general practice patients.
    Shah SH; Shah IS; Turnbull G; Cunningham K
    Br J Clin Pract; 1994; 48(4):185-9. PubMed ID: 7917797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.